Lantheus Holdings, Inc. (LNTH)
99.96
+0.31
(+0.31%)
USD |
NASDAQ |
Oct 02, 16:00
99.98
+0.02
(+0.02%)
After-Hours: 20:00
Lantheus Holdings Cash from Operations (TTM) : 412.80M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 412.80M |
| March 31, 2026 | 407.70M |
| December 31, 2025 | 390.14M |
| September 30, 2025 | 455.36M |
| June 30, 2025 | 525.13M |
| March 31, 2025 | 522.74M |
| December 31, 2024 | 542.42M |
| September 30, 2024 | 499.31M |
| June 30, 2024 | 440.98M |
| March 31, 2024 | 324.00M |
| December 31, 2023 | 305.26M |
| September 30, 2023 | 298.32M |
| June 30, 2023 | 275.15M |
| March 31, 2023 | 380.02M |
| December 31, 2022 | 281.78M |
| September 30, 2022 | 190.32M |
| June 30, 2022 | 101.09M |
| March 31, 2022 | 54.36M |
| December 31, 2021 | 53.92M |
| September 30, 2021 | 45.60M |
| June 30, 2021 | 46.40M |
| March 31, 2021 | 16.81M |
| December 31, 2020 | 16.40M |
| September 30, 2020 | 33.25M |
| June 30, 2020 | 54.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 79.32M |
| December 31, 2019 | 80.38M |
| September 30, 2019 | 75.27M |
| June 30, 2019 | 73.10M |
| March 31, 2019 | 72.33M |
| December 31, 2018 | 61.19M |
| September 30, 2018 | 56.97M |
| June 30, 2018 | 48.30M |
| March 31, 2018 | 48.59M |
| December 31, 2017 | 54.78M |
| September 30, 2017 | 54.47M |
| June 30, 2017 | 54.32M |
| March 31, 2017 | 51.39M |
| December 31, 2016 | 49.64M |
| September 30, 2016 | 49.49M |
| June 30, 2016 | 39.46M |
| March 31, 2016 | 10.38M |
| December 31, 2015 | 21.76M |
| September 30, 2015 | 5.261M |
| June 30, 2015 | 20.36M |
| March 31, 2015 | 26.81M |
| December 31, 2014 | 11.59M |
| September 30, 2014 | 11.59M |
| June 30, 2014 | -4.63M |
| March 31, 2014 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Biomerica, Inc. | -3.421M |
| Univec, Inc. | -15.55M |
| Indivior Pharmaceuticals, Inc. | -48.64M |
| Zomedica Corp. | -13.15M |
| Bristol Myers Squibb Co. | 12.78B |